ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    The Effects of Change in Body Mass Index on Morbidity and Mortality After Liver Transplantation

    B. Kashat,2 A. Prushani,1 S. Jafri.1

    1Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, MI; 2University of Michigan, Ann Arbor, MI.

    AIM: Typically, a large BMI (body mass index) is associated with poor health as it can lead to a variety of diseases; we investigate frequency…
  • 2015 American Transplant Congress

    Graft-Versus-Host Disease After Orthotopic Liver Transplantation: Multivariate Analysis of Risk Factors

    M. Elfeki, P. Genco, S. Pungpapong, J. Nguyen, D. Harnois.

    Transplantation, Mayo Clinic, Jacksonville, FL; Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL.

    Introduction:Acute graft versus host disease (GVHD) is a rare fatal complication following orthotopic liver transplantation (OLT). It involves activation of donor T lymphocytes by antigen…
  • 2015 American Transplant Congress

    Improved Renal Function Post-Liver Transplant With Earlier Everolimus Conversion

    S. Lin,1 M. Zimmerman,2 V. Lewis,1 S. Biggins,3 C. Ruller,4 I. Kam,4 T. Nydam.4

    1Pharmacy Dept, University of Colorado Hospital, Aurora; 2Division of Transplant Surgery, Medical College of Wisconsin, Wisconsin; 3Division of Gastroenterology/Hepatology, University of Colorado, Aurora; 4Division of Transplant Surgery, University of Colorado, Aurora.

    Calcineurin inhibitors (CNI) play an important role in preventing acute rejection (AR) post-liver transplant. Its long-term use is limited by development of nephrotoxicity. Optimal timing…
  • 2015 American Transplant Congress

    Early Vs. Late Acute Antibody Mediated Rejection Among Renal Transplant Recipients in Terms of Its Response to Rituximab Therapy-Single Center Expereince

    N. Nampoory, T. Alotaibi, O. Gheith, M. Halim, T. Mahmoud, P. Nair, M. Abdulmoneim, S. Alwaheb, R. Hasan.

    Nephrology, OTC of Kuwait, kuwait, Kuwait.

    IntroductionThere are no comparable trials concerning the use of rituximab among renal transplant recipients with acute antibody mediated rejection.Aim of the study:We aimed to compare…
  • 2015 American Transplant Congress

    Incidence and Risk Factors for Infectious Complications in Liver Transplant Patients Converted to Everolimus

    A. Islam,1 J. DeVos,2 L. Teeter,3 E. Graviss,3 S. Gordon-Burroughs,1 A. Saharia,1 C. Mobley,1 A. Gaber,1 R. Ghobrial.1

    1Department of Surgery, Houston Methodist Hospital, Houston, TX; 2Department of Pharmacy, Houston Methodist Hospital, Houston, TX; 3Department of Pathology & Genomic Medicine, Houston Methodist Hospital, Houston, TX.

    AIM:Immunosuppression with an mTOR inhibitor plus calcineurin inhibitor (CNI) minimization is increasingly used in liver transplantation to protect against the nephrotoxic and neurotoxic side effects…
  • 2015 American Transplant Congress

    Maximizing Peri-Operative Value-Based Care in Kidney Transplant Induction

    J. Fleming,1 J. Casale,1 K. Covert,1 K. Boyle,1 D. Taber,2 H. Meadows,1 C. Mardis,1 N. Pilch,1 M. Posadas-Salas,3 T. Srinivas,3 C. Bratton,2 J. McGillicuddy,2 K. Chavin,2 P. Baliga.2

    1Pharmacy, MUSC, Charleston, SC; 2Surgery, MUSC, Charleston, SC; 3Nephrology, MUSC, Charleston, SC.

    Due to the dwindling reimbursement for kidney transplants (KTx), there must be a continuous effort to provide the best value-based care. The purpose of this…
  • 2015 American Transplant Congress

    Hospital Characteristics Mediate Variation in Cirrhosis Mortality in Transplant and Non-Transplant Facilities

    A. Mathur,1 A. Chakrabarti,2 K. Sheetz,2 J. Mellinger,3 M. Volk,3 N. Katariya,1 A. Singer,1 W. Hewitt,1 K. Reddy,1 A. Moss.1

    1Surgery, Mayo Clinic Arizona, Phoenix, AZ; 2Surgery, University of Michigan, Ann Arbor, MI; 3Medicine, University of Michigan, Ann Arbor, MI.

    Hospitals vary significantly in cirrhosis mortality. We aimed to determine whether hospital structural characteristics mediate this effect.Methods: We used 2009 data from the HCUP Nationwide…
  • 2015 American Transplant Congress

    Assessment of Actual Pediatric Organ Donation Potential: Neurologic and Circulatory Determination of Death at a Children's Hospital

    C. Aguayo,1 E. Bennett,2 J. Sweney,2 C. Myrick,1 S. Bratton.2

    1Intermountain Donor Services, Salt Lake City, UT; 2Pediatrics, University of Utah, Salt Lake City, UT.

    BACKGROUND AND OBJECTIVES: Organ donation after circulatory determination of death (DCDD) is increasing. DCDD offers potential for additional abdominal organ donation. We evaluated all dying…
  • 2015 American Transplant Congress

    Declaring a Patient Brain Dead on Extracorporeal Membrane Oxygenation (ECMO): Are There Guidelines or Misconceptions?

    K. Kreitler,1 N. Cavarocchi,1 H. Hirose,1 S. West,2 R. Hasz,2 M. Ghobrial,3 R. Bell.3

    1Department of Surgery, Thomas Jefferson University Hospital, Philadelphia, PA; 2Gift of Life Donor Program, Philadelphia, PA; 3Department of Neurology, Thomas Jefferson University Hospital, Philadelphia, PA.

    Purpose: With the rapid growth of ECMO and the accumulating evidence that organs from ECMO donors can be safely transplanted, we reviewed the practice variations…
  • 2015 American Transplant Congress

    Should We Ever Pay Living Kidney Donors? Focus Group Study of Public Opinion

    A. Tong,1,2 A. Ralph,1,2 J. Chapman,3 G. Wong,1,2,3 J. Gill,4 M. Josephson,5 C. Hanson,1,2 J. Craig.1,2

    1School of Public Health, The University of Sydney, Sydney, Australia; 2Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, Australia; 3Centre for Transplant and Renal Research, Westmead Hospital, Sydney, Australia; 4Division of Nephrology, University of British Columbia, Vancouver, Canada; 5Department of Medicine, University of Chicago, Chicago.

    Background: The unmet demand for kidney transplantation has generated intense controversy about introducing incentives for living kidney donors to increase donation rates. Such debates may…
  • « Previous Page
  • 1
  • …
  • 1407
  • 1408
  • 1409
  • 1410
  • 1411
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences